ストックスクリーナーアプリを入手
1.71
7.32%
-0.135
前日終値:
$1.845
開ける：
$1.82
24時間の取引高:
2.76M
Relative Volume:
0.40
時価総額：
$544.56M
収益：
-
当期純損益:
$-283.26M
株価収益率:
-1.1633
EPS:
-1.47
ネットキャッシュフロー:
$-273.61M
1週間 パフォーマンス:
-25.97%
1か月 パフォーマンス:
-33.98%
6か月 パフォーマンス:
-60.05%
1年 パフォーマンス:
-82.90%
1日の値動き範囲:
$1.675
$1.84
1週間の範囲:
$1.675
$2.43
52週間の値動き範囲:
$1.52
$10.50
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.71 | 544.56M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - PR Newswire
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Bank of New York Mellon Corp Acquires 9,905 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Seattle biotech firm faces investor lawsuit over alleged misleading statements - The Business Journals
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA - GlobeNewswire
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action ... - Eagle-Tribune
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Investors in Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA - TradingView
Sana Biotechnology, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP Before May 20, 2025 to Discuss Your Rights – SANA - MSN
Shareholders that lost money on Sana Biotechnology, Inc. - GlobeNewswire
No Stopping Sana Biotechnology Inc (NASDAQ: SANA)’s Stock Plunged? - Stocks Register
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA - TradingView
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - PR Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421 - Seeking Alpha
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire
Seattle Biotech Duped Investors On Drug Progress, Suit Says - Law360
Investor Alert: Robbins LLP Informs Investors of the Sana Biotechnology, Inc. Class Action Lawsuit - The Eastern Progress Online
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
SANA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Sana Investor Says It Hid Low Cash Before Record Stock Selloff - Bloomberg Tax
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Sana Biotechnology, Inc. (SANA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - TradingView
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sana Biotechnology, Inc. (SANA) - TradingView
Research Analysts Set Expectations for SANA Q1 Earnings - Defense World
Sana Biotechnology’s SWOT analysis: stock faces pivotal year amid strategic shift By Investing.com - Investing.com South Africa
Sana Biotechnology’s SWOT analysis: stock faces pivotal year amid strategic shift - Investing.com
Sana Biotechnology’s (SANA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sana Biotechnology (NASDAQ:SANA) Upgraded to Outperform at Citizens Jmp - Defense World
Sana Biotechnology Faces Uncertainty as Financial Struggles Threaten Future Operations - TipRanks
Sana Biotechnology (NASDAQ:SANA) Sees Unusually-High Trading Volume After Strong Earnings - Defense World
Citizens Capital Markets Upgrades Sana Biotechnology (SANA) - Nasdaq
Sana Biotechnology stock upgraded at Citizens (SANA:NASDAQ) - Seeking Alpha
Sana Biotechnology upgraded at Citizens on valuation - MSN
Sana stock holds $11 target post-positive trial update By Investing.com - Investing.com Canada
Sana Biotech stock rating upgraded to Market Outperform By Investing.com - Investing.com UK
Sana Biotechnology Reports 2024 Financial Results and Progress - TipRanks
Sana: Q4 Earnings Snapshot - mySA
Sana Biotechnology shares rise on narrower-than-expected loss By Investing.com - Investing.com South Africa
Sana Biotechnology shares rise on narrower-than-expected loss - Investing.com
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - TradingView
Sana Biotechnology, Inc. Reports Positive 12-Week Clinical Results for Type 1 Diabetes Therapy and Financial Overview for Q4 2024 - Nasdaq
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
Sana Biotechnology Inc (SANA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):